These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8800940)

  • 61. Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
    Ebers GC; Sadovnick AD; Dyment DA; Yee IM; Willer CJ; Risch N
    Lancet; 2004 May; 363(9423):1773-4. PubMed ID: 15172777
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
    Nielsen NM; Frisch M; Rostgaard K; Wohlfahrt J; Hjalgrim H; Koch-Henriksen N; Melbye M; Westergaard T
    Mult Scler; 2008 Jul; 14(6):823-9. PubMed ID: 18573841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study.
    Marrosu MG; Cocco E; Lai M; Spinicci G; Pischedda MP; Contu P
    Lancet; 2002 Apr; 359(9316):1461-5. PubMed ID: 11988243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Approaches to familial aggregation: hypothesis testing and estimation when families are selected through parent probands under a variant of single ascertainment.
    Wickramaratne PJ
    Hum Hered; 2004; 57(4):179-90. PubMed ID: 15583423
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Empiric recurrence risks for use in the genetic counselling of multiple sclerosis patients.
    Sadovnick AD
    Am J Med Genet; 1984 Mar; 17(3):713-4. PubMed ID: 6711622
    [No Abstract]   [Full Text] [Related]  

  • 66. Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.
    Gajofatto A; Stefani A; Turatti M; Bianchi MR; Lira MG; Moretto G; Salviati A; Benedetti MD
    Eur J Neurol; 2013 Apr; 20(4):697-703. PubMed ID: 23279712
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The genetics and genetic epidemiology of multiple sclerosis: the "hard facts".
    Sadovnick AD
    Adv Neurol; 2006; 98():17-25. PubMed ID: 16400824
    [No Abstract]   [Full Text] [Related]  

  • 68. Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.
    Nielsen NM; Westergaard T; Frisch M; Rostgaard K; Wohlfahrt J; Koch-Henriksen N; Melbye M; Hjalgrim H
    Arch Neurol; 2006 Jul; 63(7):1001-4. PubMed ID: 16831970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study.
    Sindet-Pedersen C; Bruun Oestergaard L; Gundlund A; Fosbøl EL; Aasbjerg K; Langtved Pallisgaard J; Gislason G; Torp-Pedersen C; Bjerring Olesen J
    PLoS One; 2016; 11(12):e0169055. PubMed ID: 28033406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heterogeneity in multiple sclerosis: comparison of clinical manifestations in relatives.
    Sadovnick AD; Hashimoto LL; Hashimoto SA
    Can J Neurol Sci; 1990 Nov; 17(4):387-90. PubMed ID: 2276095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The genetic contribution to multiple sclerosis. Evidence from North-East England.
    Roberts DF; Bates D
    J Neurol Sci; 1982 May; 54(2):287-93. PubMed ID: 7097301
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The frequency of relapse in multiple sclerosis. A study based on 245 cases.
    Lhermitte F; Marteau R; Gazengel J; Dordain G; Deloche G
    Z Neurol; 1973 Aug; 205(1):47-59. PubMed ID: 4126737
    [No Abstract]   [Full Text] [Related]  

  • 73. Childhood multiple sclerosis--the long view from Scotland.
    Brett E
    Dev Med Child Neurol; 1995 Nov; 37(11):1027-30. PubMed ID: 8566451
    [No Abstract]   [Full Text] [Related]  

  • 74. Familial multiple sclerosis in Poland. 2. Clinical and genealogical analysis.
    Cendrowski WS
    J Neurol Sci; 1967; 4(2):195-8. PubMed ID: 6037094
    [No Abstract]   [Full Text] [Related]  

  • 75. An easy method of calculating approximate recurrence risks using a multifactorial model of disease transmission.
    Hutchinson TP
    Ann Hum Genet; 1980 Jan; 43(3):285-93. PubMed ID: 7362204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Do we have equipoise when it comes to how we treat active multiple sclerosis?
    Giovannoni G
    Lancet Neurol; 2019 Oct; 18(10):909-911. PubMed ID: 31375367
    [No Abstract]   [Full Text] [Related]  

  • 77. Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets.
    Sharma Y; Gupta JK; Babu MA; Singh S; Sindhu RK
    J Mol Neurosci; 2024 Oct; 74(4):101. PubMed ID: 39466510
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MSGD: a manually curated database of genomic, transcriptomic, proteomic and drug information for multiple sclerosis.
    Wu T; Hou Y; Xin G; Niu J; Peng S; Xu F; Li Y; Chen Y; Yu Y; Zhang H; Kong X; Cao Y; Ning S; Wang L; Hao J
    Database (Oxford); 2024 May; 2024():. PubMed ID: 38788333
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.
    Montgomery TL; Peipert D; Krementsov DN
    Immunol Rev; 2024 Aug; 325(1):131-151. PubMed ID: 38717158
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Earlier age of symptom onset in younger generation of familial cases of multiple sclerosis.
    Jovanovic A; Pekmezovic T; Mesaros S; Novakovic I; Peterlin B; Veselinovic N; Tamas O; Ivanovic J; Maric G; Andabaka M; Momcilovic N; Drulovic J
    Neurol Sci; 2024 Sep; 45(9):4463-4469. PubMed ID: 38594425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.